MOTS-c 40mg

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

Quickstart Highlights

MOTS-c is a 16-amino-acid mitochondrial-derived peptide (a short peptide encoded within mitochondrial DNA) that helps regulate metabolic homeostasis, mainly by activating the AMPK energy-sensing pathway[1][2]. In preclinical work it has been described as an “exercise-mimetic,” supporting insulin sensitivity, glucose handling and fat oxidation. This educational page outlines a once-daily subcutaneous approach with a dilution chosen so doses land on easy-to-read insulin-syringe marks. It is an unapproved research chemical, not a medicine, and there are no completed human efficacy trials — presented for research and educational use only.

Add 3.0 mL bacteriostatic water to one 20 mg vial → ~6.67 mg/mL (6,667 mcg/mL), the largest practical dilution for accurate dosing.
200–1,000 mcg once daily, titrated upward gradually over an ~10-week course in roughly 200 mcg steps.
At ~6.67 mg/mL, 1 unit ≈ 66.7 mcg; 200 mcg ≈ 3 units and 1,000 mcg ≈ 15 units on a U-100 syringe.
Lyophilized: store at −20 °C (−4 °F); once reconstituted, refrigerate at 2–8 °C (35.6–46.4 °F), do not freeze the solution, and use within about 7 days.
Important: Start with the Prep & Injection Guide — it covers the preparation and safety basics every protocol on this site assumes.

Dosing & Reconstitution Guide

A single practical dilution with accurate once-daily dosing, step by step

Standard / Gradual Approach (3 mL = ~6.67 mg/mL)

Phase / Week(s)	Dose & Frequency	Volume (U-100 units / mL)
Weeks 1–2	200 mcg (1× daily)	~3 units (0.03 mL)
Weeks 3–4	400 mcg (1× daily)	~6 units (0.06 mL)
Weeks 5–6	600 mcg (1× daily)	~9 units (0.09 mL)
Weeks 7–8	800 mcg (1× daily)	~12 units (0.12 mL)
Weeks 9–10+	1,000 mcg (1× daily)	~15 units (0.15 mL)

Reconstitute: Add 3.0 mL bacteriostatic water to one 20 mg vial → final concentration ~6.67 mg/mL (6,667 mcg/mL).
Typical daily range: 200–1,000 mcg once daily, raised gradually over an ~10-week course.
Easy measuring: At ~6.67 mg/mL, 1 unit ≈ 66.7 mcg on a U-100 syringe. Using the large 3.0 mL dilution keeps the working dose at 3–15 units for reliable measuring accuracy.
Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F), do not freeze the mixed solution, and use within about 7 days.
Frequency: one subcutaneous injection each day, holding each dose level for about two weeks before stepping up as tolerated[7]. These figures come from commonly cited reference protocols and animal-to-human extrapolation, not from approved human dosing.

Reconstitution Steps

Draw 3.0 mL of bacteriostatic water into a sterile syringe.

Release it slowly down the vial’s inner wall to limit foaming.
Swirl or roll gently until fully dissolved — don’t shake.
Label with the date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), shielded from light.
The 3.0 mL dilution is deliberately large so each dose reads at several units or more, where U-100 syringe markings are most precise. Avoid freezing the reconstituted solution, since freeze–thaw can denature the peptide.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Quantities below assume an 8–16 week course of once-daily injections with gradual titration.

A single 20 mg vial covers roughly four weeks at the lower titration doses, so plan vials to your cycle length and target dose.
8 weeks: ~2 vials
12 weeks: ~3 vials
16 weeks: ~5 vials
Per injection: 1 syringe
8 weeks (once daily): ~56 syringes
16 weeks (once daily): ~112 syringes
Use ~3.0 mL per 20 mg vial for reconstitution.
8 weeks (3 vials): ~9 mL → 1 bottle
16 weeks (9 vials): ~27 mL → 3 bottles
One for the vial stopper + one for the injection site each day.
Per injection: 2 swabs
8 weeks (once daily): ~112 swabs → 1–2 boxes

Protocol Overview

A concise summary of the once-daily regimen, drawn from commonly cited reference protocols.

▪Goal: Support metabolic homeostasis, insulin sensitivity and age-related physical performance — effects reported preclinically, not established in humans[1][4].
▪Schedule: Daily subcutaneous injections for 8–12 weeks, optionally extended to ~16 weeks for longer research goals.
▪Dose Range: 200–1,000 mcg per day with gradual titration over roughly 10 weeks.
▪Reconstitution: 3.0 mL bacteriostatic water per 20 mg vial gives ~6.67 mg/mL for accurate unit measurements.
▪Storage: Keep the dry vial frozen at −20 °C (−4 °F); once mixed, refrigerate at 2–8 °C and do not freeze the solution.

Dosing Protocol

A suggested daily titration approach based on common reference doses and animal-to-human extrapolation.

▪Start: Begin at 200 mcg once daily for two weeks to gauge tolerability.
▪Titrate: Increase by roughly 200 mcg every two weeks as tolerated (400 → 600 → 800 mcg).
▪Target: Reach up to about 1,000 mcg (1.0 mg) daily by weeks 9–10+ if well tolerated.
▪Cycle Length: Typically 8–12 weeks; some references extend to ~16 weeks.
▪Timing: Inject at a consistent time each day and rotate injection sites systematically.

Storage Instructions

Correct storage is what preserves the peptide’s stability and activity.

▪Lyophilized: Hold the dry vial at −20 °C (−4 °F) in dry, dark conditions and limit moisture exposure[9].
▪Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 7 days for best potency; do not freeze the mixed solution, as freezing can denature peptides[11].
▪Handling: Let frozen vials warm to room temperature before opening so condensation won’t form, and keep the solution clear of heat and direct light.
▪Freeze–thaw: Prepare single-use aliquots if needed and avoid repeated freeze–thaw cycles of the reconstituted solution.

Important Notes

Practical points that keep daily administration safe and consistent.

▪Sterile technique: Use a fresh sterile U-100 insulin syringe each time and drop it straight into a puncture-proof sharps container afterward.
▪Site rotation: Move between abdomen, thighs and upper arms to reduce local irritation and lipohypertrophy[11].
▪Slow injection: Push the plunger slowly and pause a few seconds before withdrawing the needle to prevent backflow.
▪Recordkeeping: Log the daily dose, injection site and any observations to keep the protocol consistent.
▪Regulatory note: MOTS-c is not FDA-approved for human administration and is an unapproved research chemical; discontinue and consult a professional if any concerning symptoms arise[8].

How This Works

MOTS-c is a 16-amino-acid mitochondrial-derived peptide (MDP) — a short peptide encoded within a region of mitochondrial DNA rather than the cell nucleus. It behaves like a metabolic “stress signal” that helps cells optimize energy use during nutrient stress or exercise[2].

Its core proposed mechanism is activation of the AMPK energy-sensing pathway. In preclinical work, MOTS-c is described as interfering with the folate cycle, leading to a build-up of AICAR (an AMP analog) that switches on AMPK[1][2]. Activated AMPK shifts cells toward an energy-efficient state — supporting glucose uptake, fatty-acid oxidation and mitochondrial respiration while dialing down fat storage and gluconeogenesis.
Under stress, MOTS-c has also been reported to move into the cell nucleus and help turn on antioxidant and stress-response genes — a form of retrograde signalling from the mitochondria to the nucleus[2]. Because these effects echo what happens with exercise and with metformin at a cellular level, MOTS-c is often referred to as an “exercise-mimetic”[4].
Important caveat: the evidence for these mechanisms and benefits is preclinical — based on cell and animal studies. There are no completed human efficacy trials of MOTS-c; the closest human data involve a modified analog (CB4211) studied for tolerability[7][8]. Metabolic, performance and longevity claims should be read as hypotheses, not established outcomes.
MOTS-c is not an approved medicine. It is an unapproved research chemical presented here for research and educational purposes only.

Lifestyle Factors

Habits that may complement the protocol, given MOTS-c’s metabolic mechanisms.

▪Nutrition: Pair with a balanced, protein-forward diet tailored to your energy needs.
▪Activity: Combine resistance training and aerobic activity to reinforce metabolic adaptations and AMPK signalling[4].
▪Sleep: Aim for 7–9 hours to support mitochondrial health and recovery.
▪Fasting: Intermittent fasting or modest caloric restriction may overlap with MOTS-c’s AMPK-mediated effects.

Potential Benefits & Side Effects

What preclinical literature describes; human evidence is absent and individual results are unknown.

▪Metabolic health (preclinical): In mouse models, MOTS-c improved insulin sensitivity and glucose handling and helped prevent diet-induced insulin resistance[1].
▪Fat & weight (preclinical): Reduced visceral fat and helped prevent obesity in mice via increased energy expenditure and fat oxidation[1].
▪Physical performance (preclinical): Described as an exercise-mimetic that enhanced exercise capacity and countered age-related decline in animal studies[4].
▪Note on humans: These benefits are not established in humans — no completed human efficacy trials of MOTS-c exist[8].
▪Injection-site reactions: Mild redness, tenderness or soreness can occur; rotating sites helps.
▪Unknown human profile: No human safety data exists for MOTS-c, so caution and monitoring are advised.
▪Research status: MOTS-c is an unapproved research chemical and is not intended for human use.

Injection Technique

General subcutaneous technique, following established clinical best-practice guidance[9][11].

▪Wash your hands well with soap and water.
▪Wipe the vial stopper with an alcohol swab and let it air-dry.
▪Choose a site (abdomen, thigh, or upper arm) and clean it with a fresh alcohol swab, letting it dry fully[11].
▪Draw the intended dose, then check for air bubbles and push any out.
▪Pinch a skinfold at the chosen site between thumb and forefinger.
▪Insert the needle into the pinch at a 45–90-degree angle (use 45 degrees if the fat layer is thin)[9].
▪Skip aspiration for subcutaneous shots — it isn’t needed[9].
▪Press the plunger slowly and steadily until it’s fully down.
▪Wait 5–10 seconds, then pull the needle straight out to prevent leakage.
▪Drop the used syringe straight into a puncture-proof sharps container — never recap a needle.
▪Return the reconstituted vial to the fridge right away.
▪Rotate the injection site each day to prevent irritation and lipohypertrophy[11].
▪Watch the site for excess redness, swelling, or signs of infection.

Recommended Source

For high-purity research peptides, we point researchers to Prime Lab Peptides for MOTS-c (20 mg).

▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA. Open source
▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.
▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.
▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.
▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
Shop at Prime Lab Peptides →

References

Reference-derived details for MOTS-c 40mg.

MOTS-C (20 mg Vial) Dosage Protocol Open source
1 Cell Metabolism (2015) The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance (Lee C, Zeng J, Drew BG, et al.). View Source ↗ Open source
2 Journal of Translational Medicine (2023) Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging (Wan W, Zhang L, Lin Y, et al.). View Source ↗ Open source
3 Journal of Molecular Medicine (2019) MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction (Lu H, Wei M, Zhai Y, et al.). View Source ↗ Open source
4 Nature Communications (2021) MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis (Reynolds JC, Lai RW, Woodhead JST, et al.). View Source ↗ Open source
5 Frontiers in Physiology (2023) Role of MOTS-c in the regulation of bone metabolism (Yi X, Hu G, Yang Y, et al.). View Source ↗ Open source
6 International Journal of Molecular Sciences (2022) MOTS-c, the Most Recent Mitochondrial-Derived Peptide in Human Aging and Age-Related Diseases (Mohtashami Z, Singh MK, Salimiaghdam N, et al.). View Source ↗ Open source
7 Cognitive Vitality Reports (2021) MOTS-c cognitive vitality profile — Alzheimer’s Drug Discovery Foundation (ADDF). View Source ↗ Open source
8 USADA Spirit of Sport (2023) What is the MOTS-c peptide? — U.S. Anti-Doping Agency education article. View Source ↗ Open source
9 CDC Vaccine Administration Guidelines Subcutaneous injection technique: angle, site selection and no-aspiration guidance. View Source ↗ Open source
10 Experimental & Molecular Medicine (2025) Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes (Kong BS, Lee H, L’Yi S, et al.). View Source ↗ Open source
11 Peptide Storage Guide Best practices for storing lyophilized and reconstituted peptides (temperature, humidity and light protection). View Source ↗ Open source
12 MedlinePlus Medical Encyclopedia Subcutaneous (SQ) injections — patient instructions for proper technique. View Source ↗ Open source
13 Prime Lab Peptides MOTS-c (10 mg) product page — purity specifications and certificates of analysis. View Source ↗ Open source

Contents